Immunotherapy duo shows promise in tough lung cancer cases
NCT ID NCT02823990
First seen Nov 10, 2025 · Last updated May 12, 2026 · Updated 24 times
Summary
This study tested a combination of two immunotherapy drugs (TG4010 and nivolumab) in 13 people with advanced non-small cell lung cancer that had already been treated. The goal was to see if the combo could shrink tumors or stop them from growing. While the treatment aims to control the disease, it is not a cure, and patients may need ongoing therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT NON-SMALL CELL LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
UCSF Medical Center-Mount Zion
San Francisco, California, 94115, United States
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
-
University of California San Diego
San Diego, California, 92103, United States
Conditions
Explore the condition pages connected to this study.